Myriad Genetics |
日期/时间 | / |
涨跌。 / 涨跌。(%) | - / |
Bid | - |
Ask | - |
打开 | - |
以往收市 | - |
高 | - |
低 | - |
成交量 [USD] | - |
成交量 [Units] | |
Price fixings | |
ISIN | US62855J1043 |
符号 | MYGN |
交易所 | IEX |
类型 | 股票 |
所有交易
交易所 | 最后的 | 成交量 | |
---|---|---|---|
NASDAQ | 21,7000 | ![]() |
319.399 |
IEX | 21,73 | ![]() |
16.095 |
Cboe US | 21,71 | ![]() |
13.730 |
TradeGate | 20,860 | ![]() |
10 |
Xetra | 20,580 | ![]() |
0 |
Hannover | 20,790 | ![]() |
0 |
Frankfurt | 20,8300 | ![]() |
0 |
Berlin | 20,810 | ![]() |
0 |
München | 20,790 | ![]() |
0 |
Hamburg | 20,790 | ![]() |
0 |
Düsseldorf | 20,250 | ![]() |
0 |
Stuttgart | 20,260 | ![]() |
0 |
Lang & Schwa.. | 20,110 | ![]() |
|
gettex | 20,240 | ![]() |
|
Quotrix | 20,9300 | ![]() |
|
London Domes.. | 22,06 | 100 |
新闻
- Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care
14.03.2022 / 12:05 - GlobeNewswire - Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
12.03.2022 / 01:05 - GlobeNewswire - Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
08.03.2022 / 13:22 - GlobeNewswire - Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference
02.03.2022 / 22:30 - GlobeNewswire - Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
24.02.2022 / 15:00 - GlobeNewswire
Personal area
Click on
to activate push quotes.
